Phreesia, Inc. (PHR) Guidance & Earnings Results

On 2026-09-02 Phreesia, Inc. reaffirmed guidance: "FY27 revenue $510M-$520M, adjusted EBITDA…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason

PHRPhreesia, Inc.Follow PHR — free

Health Information Services · Healthcare

—

Price chart with a free account

Market cap: 788.3M
P/E TTM: 74.7
Dividend yield: —
52-week: —
Next earnings: 7 Dec, in 44 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
2 Sep 26	Reaffirmed	FY27 revenue $510M-$520M, adjusted EBITDA $125M-$135M · full year
27 May 26	Reaffirmed	FY27 revenue outlook maintained at $510-520M · full year
30 Mar 26	Lowered	Revenue guidance lowered from $545-559M to $510-520M for FY2027 · full year
8 Dec 25	Raised	FY2026 revenue raised to $479-481M from $472-482M; EBITDA raised to $99-101M from $87-92M; FY2027 revenue introduced at $545-559M · full year
4 Sep 25	Reaffirmed	FY2026 revenue $472-482M · full year

Phreesia, Inc. — questions

What guidance did Phreesia, Inc. give?: On 2026-09-02: "FY27 revenue $510M-$520M, adjusted EBITDA $125M-$135M"
When does Phreesia, Inc. report earnings?: Phreesia, Inc.'s next earnings report is expected on 2026-12-07.

Every figure on this page comes from Phreesia, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.